Intellectual property protection for nano inventions

Introduction

Nanotechnology involves the manipulation of matter at the nanoscale, generally between 1 and 100 nanometres, to develop materials, devices and systems with specialised properties. Nano inventions are used in medicine, electronics, biotechnology, agriculture, cosmetics, energy and environmental protection. Examples include nanoparticles, nanocomposites, nanosensors, targeted drug-delivery systems and nano-coatings.

Intellectual property (IP) protection is important because developing nano inventions often requires substantial investment in research, specialised equipment and experimentation. Patent law is the principal mechanism for protecting such inventions, although copyright, trade secrets, industrial designs and trademarks may also apply. The main legal challenge is ensuring that an invention satisfies the requirements of novelty, inventive step and industrial applicability without granting excessively broad monopolies over scientific discoveries.

Patent protection under Indian law

The Patents Act, 1970 is the primary legislation governing patent protection in India. Under Section 2(1)(j), an invention must be a new product or process involving an inventive step and capable of industrial application. Section 2(1)(ja) defines inventive step as a feature involving technical advancement or economic significance, or both, that makes the invention non-obvious to a person skilled in the relevant field.

Nano inventions may qualify for patents when they demonstrate a specific technical contribution. For example, a newly developed nanoparticle with a distinctive structure, a novel manufacturing process or a drug-delivery system producing an improved therapeutic effect may be patentable if all statutory requirements are satisfied.

However, Section 3 excludes certain subject matter from patentability:

Section 3(c): Mere discovery of a scientific principle or naturally occurring substance is not patentable.

Section 3(d): A new form of a known substance is not patentable unless it demonstrates the required enhancement in known efficacy.

Section 3(e): Mere admixtures resulting only in the aggregation of properties are excluded.

Section 3(i): Certain methods of medical treatment are not patentable.

Section 3(j): Plants, animals and essentially biological processes are excluded, subject to statutory exceptions.

These provisions are particularly relevant where an applicant claims a naturally occurring nanoscale material or a minor modification of an existing nanoparticle.

Patentability challenges in nanotechnology

Nano inventions create several difficulties in patent examination. First, the distinction between discovery and invention can be complicated because some nanoscale properties exist naturally but become useful through technological manipulation. Second, determining inventive step may require specialised technical knowledge and comparison with rapidly developing scientific literature.

Another challenge is the sufficiency of disclosure. Section 10 of the Patents Act requires the patent specification to describe the invention and its operation or use sufficiently. Applicants must provide adequate technical information concerning particle size, composition, preparation methods, surface properties and reproducibility where relevant.

Patent claims must also be sufficiently clear and supported by the disclosure. Broad claims covering every possible use of a nanoparticle may face objections if the specification demonstrates only a limited application.

Other forms of intellectual property protection

Patent protection is not the only available mechanism. Different aspects of nano inventions may receive different forms of protection.

Trade secrets: Confidential manufacturing techniques, particle-stabilisation methods, experimental data and production parameters may be protected through confidentiality agreements and contractual arrangements. India does not have a single comprehensive trade secret statute, so protection generally relies on contract law and principles of confidentiality.

Copyright: Software used to control nanosensors, simulation programs, research reports and technical drawings may receive copyright protection under the Copyright Act, 1957. Copyright protects the expression of an idea rather than the underlying scientific concept.

Industrial designs: The Designs Act, 2000 may protect the visual features of certain nano-enabled products, provided the design satisfies the statutory requirements. It does not protect the technical function of the product.

Trademarks: Brand names and logos associated with nano-enabled products may be protected under the Trade Marks Act, 1999.

Important case laws

1. Novartis AG v. Union of India (2013)

The Supreme Court interpreted Section 3(d) of the Patents Act and rejected a patent application concerning a modified form of a known pharmaceutical substance because the required enhancement in therapeutic efficacy was not established. The judgment is relevant to nanomedicine where applicants seek patents for modified drug formulations or nanoscale versions of known substances.

2. Bishwanath Prasad Radhey Shyam v. Hindustan Metal Industries (1979)

The Supreme Court explained that an invention must involve an inventive step and cannot merely represent an obvious workshop improvement. This principle is relevant when assessing whether a new nanoparticle composition or manufacturing technique represents a genuine technological advancement.

3. Dimminaco A.G. v. Controller of Patents and Designs (2002)

The Calcutta High Court recognised that a process involving a living organism was not automatically excluded from patentability merely because the resulting product contained living material. The decision is relevant to biotechnology-based nano inventions, although it does not directly concern nanotechnology.

4. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019)

The Supreme Court set aside the Delhi High Court's decision on patent validity and restored the infringement proceedings for consideration. The dispute concerned genetically modified seeds and the relationship between patent protection and plant variety legislation. It illustrates the importance of examining statutory exclusions when technological inventions overlap with biological materials.

International legal framework

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) establishes minimum standards for patent protection among WTO members. Articles 27 and 28 address patentable subject matter and patent rights. The Patent Cooperation Treaty (PCT) provides an international application system that helps applicants seek patent protection in multiple countries, although each national patent office ultimately decides whether to grant a patent.

The World Intellectual Property Organization (WIPO) also supports international discussions concerning emerging technologies and intellectual property challenges, including nanotechnology.

Conclusion

Intellectual property protection encourages innovation in nanotechnology by allowing inventors to secure commercial rights over genuine technological advances. In India, the Patents Act, 1970 provides the principal framework, supported by copyright, design and trademark laws and contractual protection of confidential information. However, patent applicants must establish novelty, inventive step, industrial applicability and sufficient disclosure while complying with statutory exclusions.

Note: The cited judgments establish general patentability principles and are not direct judicial decisions concerning nano inventions. Their reasoning is applied by analogy to nanotechnology-related patent disputes.